Antibody Prophylaxis Against Dengue Virus 2 Infection in Non-Human Primates.

about

Dengue Virus Evades AAV-Mediated Neutralizing Antibody Prophylaxis in Rhesus Monkeys.

P2860

Q40045875-3A23618E-D256-45FD-8A0B-ED9F00D37D5A

P2860

Antibody Prophylaxis Against Dengue Virus 2 Infection in Non-Human Primates.

Item

http://www.wikidata.org/entity/Q40081626

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Antibody Prophylaxis Against Dengue Virus 2 Infection in Non-Human Primates.

@en

type

Item

label

Antibody Prophylaxis Against Dengue Virus 2 Infection in Non-Human Primates.

@en

prefLabel

Antibody Prophylaxis Against Dengue Virus 2 Infection in Non-Human Primates.

@en

P1476

Antibody Prophylaxis Against Dengue Virus 2 Infection in Non-Human Primates.

@en

P2093

Monika Simmons

http://www.w3.org/2001/XMLSchema#string

Peifang Sun

http://www.w3.org/2001/XMLSchema#string

Robert Putnak

http://www.w3.org/2001/XMLSchema#string

Timothy Burgess

http://www.w3.org/2001/XMLSchema#string

Wayne A Marasco

http://www.w3.org/2001/XMLSchema#string

P2860

Monoclonal antibody-mediated enhancement of dengue virus infection in vitro and in vivo and strategies for prevention

Dengue virus identification by the plaque reduction neutralization test

Lethal antibody enhancement of dengue disease in mice is prevented by Fc modification

Characterization of Antibody Responses to Combinations of a Dengue Virus Type 2 DNA Vaccine and Two Dengue Virus Type 2 Protein Vaccines in Rhesus Macaques

Neutralization and antibody-dependent enhancement of dengue viruses

Antibody-dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever

Safety and immunogenicity of attenuated dengue virus vaccines (Aventis Pasteur) in human volunteers.

Molecular signatures of hemagglutinin stem-directed heterosubtypic human neutralizing antibodies against influenza A viruses.

Passive transfer of antibodies protects immunocompetent and imunodeficient mice against lethal Ebola virus infection without complete inhibition of viral replication.

Isolation of a temperature-sensitive dengue-2 virus under conditions suitable for vaccine development

P304

1148-1156

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4269/AJTMH.16-0319

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-09-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27645784

http://www.w3.org/2001/XMLSchema#string

P921

Dengue virus

P932

5094231

http://www.w3.org/2001/XMLSchema#string

Antibody Prophylaxis Against Dengue Virus 2 Infection in Non-Human Primates.

about

P2860

P2860

Antibody Prophylaxis Against Dengue Virus 2 Infection in Non-Human Primates.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932